Prof. Eitan Friedman

Prof. Eitan Friedman is a highly experienced medical oncologist with over 42 years of experience in cancer care and research. He works at the renowned Sheba Medical Centre, Tel HaShomer, in Tel Aviv, where he leads pioneering research in oncology. Prof. Friedman has been instrumental in advancing chemotherapy treatments and targeted therapies for various cancers, including breast, lung, and colorectal cancers. His commitment to both clinical care and research has made him a prominent figure in the field of oncology.

Prof. Friedman has made significant contributions to cancer research, particularly in the areas of targeted therapy and immuno-oncology. He has published numerous studies in leading medical journals and has been a key participant in international oncology trials. His research focuses on improving cancer treatment efficacy and minimizing side effects, with a particular emphasis on personalized medicine.

• Lifetime Achievement Award, Israeli Medical Association, 2020

• Best Cancer Researcher, Sheba Medical Centre, 2015

• International Oncology Leadership Award, European Society of Medical Oncology, 2012

Prof. Eitan Friedman has published more than 100 peer-reviewed articles and research papers in high-impact oncology journals. His work on the development of novel targeted therapies for cancer patients has been widely cited, and he continues to be a leading voice in advancing cancer treatment protocols globally.